Chris Edwards

Consultant Rheumatologist | Honorary Professor of Rheumatology @southamptonCRF | Past Chair of EULAR Education Committee @eular_org

[Chris Edwards @ChrisEdwardsRh]

@AdamMGrant Interesting when we are all trying to get rid of textbooks!

[Chris Edwards @ChrisEdwardsRh]

Really enjoyed being part of the #PARE24 meeting. Inspiring.

[Alessia Alunno @alessia_alunno]

📢 Are you a person living with a #rheumatic and musculoskeletal disease? Share your thoughts on #cardiovascular risk and prevention in this 15-min survey.

https://t.co/exTyeoC0mk

🇬🇧🇮🇹🇪🇸🇩🇪🇵🇹🇭🇺 (and more to come)

You can help improving the care of people with RMDs! Thank you!

[Lupus UK @LUPUSUK]

Join over 9,000 people who have already spared 60 secs to take @WeAreSRUK's online symptom test. #BePartOfTheAnswer by helping to unlock potential breakthroughs in diagnosis and treatment for debilitating autoimmune conditions. https://t.co/bA0nBDsxro

[Chris Edwards @ChrisEdwardsRh]

The dates are in for Ten Topics in Rheumatology 2025
Save the 3rd and 4th July 2025!
https://t.co/FYhMjMvzAm

[Chris Edwards @ChrisEdwardsRh]

@dr_emrebilgin @eular_org @EMEUNET @k_lauper @KragstrupTW @DiegoBenavent @vincevenerito Now I have to compete with shirts as well as rheumatology knowledge!

[Chris Edwards @ChrisEdwardsRh]

Great to be park of the Sri Lankan Rheumatology meeting speaking about NPSLE.
Key points:
- Is it driven by inflammation or thrombosis?
- Increasing nightmares can predict a flare

[Chris Edwards @ChrisEdwardsRh]

@alessia_alunno @eular_org @UEMSEurope @WinEd2011 @CastrejonIsabel @FranciscaSivera @TadejAvcin EULAR and UEMS working together to improve rheumatology training across Europe and beyond........

[Chris Edwards @ChrisEdwardsRh]

@alessia_alunno @eular_org @UEMSEurope @WinEd2011 @CastrejonIsabel @FranciscaSivera @TadejAvcin Great meeting....amazing how much rheumatology you learn by writing MCQ questions with colleagues!

[Chris Edwards @ChrisEdwardsRh]

Planning is now underway for EULAR Autumn course 2025!

[Chris Edwards @ChrisEdwardsRh]

Lots of thought provoking talks and discussions at the EULAR Autumn course. Was challenged to think about rapid tapering of steroids but not be so concerned about very low dose....

[Alessia Alunno @alessia_alunno]

The @eular_org 🤝@UEMSEurope partnership takes another step forward! Grateful to be part of this amazing team shaping the future of European #rheumatology training 📚💻
#rheumedu

[Alessia Alunno @alessia_alunno]

📣To all physicians and health professionals involved in the care of people with RMDs!

Are you aware of the #cardiovascular risk of your patients and of @eular_org recommendations on this topic?

Take this 10-minute survey and pls repost! Thanks!

👉🏻 https://t.co/kXrbCmLU7U

[Chris Edwards @ChrisEdwardsRh]

What a great experience it is to attend meetings like APLAR and hear the views and expertise of colleagues from across the world. Thank you APLAR. Thank you Singapore.

[EULAR @eular_org]

📢Upcoming registration deadline for the 4th EULAR Autumn Course Days 2024: A postgraduate course for rheumatologists!

🔔Registration deadline: 8 September 2024
📍Amsterdam, Netherlands
📆25 - 27 October 2024

Register here👉https://t.co/PhYDZHOGLi

#EULAR #eularEDUCATION

[EULAR @eular_org]

📢 Take the EULAR Impact of RMDs Survey and share how RMDs impact your healthcare, social life, and work.

🔗 Take the Survey Now: https://t.co/qnAPZgtpmy

#eularRESEARCH #PatientVoice #RMDimpact

[EULAR @eular_org]

🚀Join us on our #EULAR - Educational Webinar Series: "GCA: what is new?"

💻Wednesday, 30 October 2024, 18:00-18:45 CET

Register here👉https://t.co/8y8L034tX0

[EULAR @eular_org]

🚀Join us on our #EULAR - Educational Webinar Series: "Brain and RMDs- what have we learnt with functional imaging?"

💻Wednesday, 4 September 2024, 18:00-18:45 CEST

Register here👉https://t.co/iVgzMUlhXz

[Chris Edwards @ChrisEdwardsRh]

Professor Andy Cope @APLAR in Singapore discussing the significant symptom burden in the pre-RA state

[Chris Edwards @ChrisEdwardsRh]

Professor Lai-Shan Tam reminding us all of the need to consider CV risk in people with inflammatory disease @APLAR in Singapore